Aaron S Kesselheim Rethinking global access to vaccines
نویسندگان
چکیده
منابع مشابه
An Uninformative Truth: The Logic of Amarin’s Off-Label Promotion
Spencer Phillips Hey and Aaron Kesselheim propose that informativeness-asserting scientific facts-rather than truthfulness ought to be the standard for regulating commercial speech about pharmaceuticals.
متن کاملPaying Physicians to Prescribe Generic Drugs and Follow-On Biologics in the United States
Aaron Kesselheim and colleagues examine potential strategies to promote greater prescribing of generic drugs and follow-on biologics.
متن کاملBiomarker-Defined Subsets of Common Diseases: Policy and Economic Implications of Orphan Drug Act Coverage
Aaron Kesselheim and colleagues examine orphan-designated drugs approved between 2009 and 2015 in the United States.
متن کاملCreating a medical, ethical, and legal framework for complex living kidney donors.
Peter P. Reese,* Arthur L. Caplan, Aaron S. Kesselheim, and Roy D. Bloom* *Renal, Electrolyte and Hypertension Division, Department of Medicine, and Center for Bioethics, University of Pennsylvania, Philadelphia, Pennsylvania; and Brigham and Women’s Hospital, Department of Medicine, and Harvard Medical School, Boston, Massachusetts Clin J Am Soc Nephrol 1: 1148–1153, 2006. doi: 10.2215/CJN.021...
متن کاملPractical, legal, and ethical issues in expanded access to investigational drugs.
The Food and Drug Administration (FDA) reviews clinical-trial data for new drugs and determines whether the benefits of these drugs outweigh the risks.1 This requirement, legislated in 1962,2 raised the bar to approval and reduced the likelihood that new drugs would be ineffective or cause major health problems. Developing such data about investigational drugs takes time for the assessment of p...
متن کامل